“We are making this organizational change in response to current and anticipated production requirements, the volumes required for some of our new medicine formulations, and shift schedule adjustments,” a Genentech spokeswoman told STAT.
The company will reduce its workforce by the end of the year.
More articles on supply chain:
6 ways the proposed Republican tax overhaul could impact pharma
3 latest FDA approvals
FDA: EpiPen failures attributed to 7 deaths this year
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
